Ono Pharmaceutical (United States)

1.7k papers and 46.8k indexed citations i.

About

In recent decades, authors affiliated with Ono Pharmaceutical (United States) have published 1.7k papers, which have received a total of 46.8k indexed citations. Scholars at this organization have produced 375 papers in Oncology, 293 papers in Molecular Biology and 168 papers in Pathology and Forensic Medicine on the topics of Multiple Sclerosis Research Studies (125 papers), Cancer Immunotherapy and Biomarkers (109 papers) and Polyomavirus and related diseases (96 papers). Their work is cited by papers focused on Oncology (10.5k citations), Molecular Biology (8.4k citations) and Immunology (6.6k citations). Authors at Ono Pharmaceutical (United States) collaborate with scholars in United States, Germany and France and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Ono Pharmaceutical (United States)'s most productive authors include J. H. Sinfelt, Constantine Tsonopoulos, Robert J. Lang, Zigmond W. Wilchinsky, J. W. Dunkin, R. F. Schaufele, Werner Dietz, W. Philippoff, F. B. Sprow and M.A. Goodman.

In The Last Decade

Fields of papers published by authors at Ono Pharmaceutical (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Ono Pharmaceutical (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Ono Pharmaceutical (United States) at the time of their publication.

Countries citing scholars working at Ono Pharmaceutical (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Ono Pharmaceutical (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ono Pharmaceutical (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ono Pharmaceutical (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Laboratoire de Cristallographie et RMN Biologiques Breakdown of academic impact, for scholars at Shanghai Children's Hospital Breakdown of academic impact, for scholars at Laboratoire Navier Breakdown of academic impact, for scholars at Institut Universitaire de Gériatrie de Montréal Breakdown of academic impact, for scholars at Akebono (Japan) Breakdown of academic impact, for scholars at Laboratoire de Physique Théorique et Modèles Statistiques Breakdown of academic impact, for scholars at Korea Institute of Brain Science Breakdown of academic impact, for scholars at Bates College
Rankless by CCL
2025